Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. STKE, 1 October 2002
Vol. 2002, Issue 152, p. tw360
[DOI: 10.1126/stke.2002.152.tw360]

EDITORS' CHOICE

Drug Abuse More Dangers from Designer Drugs

In recent years, MDMA, or "ecstasy," has become a widespread recreational drug in the Western world. Current research suggested already that this substance is selectively damaging serotoninergic synaptic transmission. Ricaurte et al. describe how ecstasy causes not only serotoninergic, but also dopaminergic neurotoxicity, in monkeys. MDMA might then interfere with motor function even when given in recreational doses. Because neuropsychiatric disorders are often related to dopamine dysfunction, recreational users may be putting themselves at risk for developing such diseases.

G. A. Ricaurte, J. Yuan, G. Hatzidimitriou, B. J. Cord, U. D. McCann, Severe dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA ("ecstasy"). Science 297, 2260-2263 (2002). [Abstract] [Full Text]

Citation: More Dangers from Designer Drugs. Sci. STKE 2002, tw360 (2002).


To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882